XML 62 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Deferred Royalty Obligation Related To The Sale Of Future Royalties (Details) - USD ($)
1 Months Ended 3 Months Ended
Jun. 30, 2022
Mar. 31, 2024
Mar. 31, 2023
Oct. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Non-cash interest expense related to the sale of future royalties   $ 1,702,000 $ 969,000  
Proceeds from royalties received   0    
Healthcare royalty partners IV, L.P | License        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty payments and commercial milestone payments $ 20,000,000      
Revenue to be received 10,000,000     $ 5,000,000
Payment to be received $ 5,000,000     $ 5,000,000
Transaction costs   $ 400,000    
Amortization, effective interest rate (as percent)   33.70%